🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

Recruitingn/aAges 18 Years - 69 YearsAllGerman Diabetes Center
NCT01055093 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of diabetes mellitus according to ADA criteria * Age 18-69 * Diabetes duration since diagnosis \< 12 months * Control cohort: proven normal glucose tolerance according to ADA criteria Exclusion Criteria: * Diabetes mellitus category 3 B-H (ADA criteria) * Pregnancy * Severe renal, liver or heart disease * malignant cancer * severe psychiatric illness or addiction * participation in an intervention trial
💊

What it tests

  • Not listed
📍

Where

1 site
German Diabetes Center
Düsseldorf, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy